Patterns of liver iron accumulation in patients with sickle cell disease and thalassemia with iron overload

European Journal of Haematology

Volumn 85, Issue 1, 2010, Pages 51-57

  Hankins, Jane S ^a   Smeltzer, Matthew P ^a   McCarville, M Beth ^a   Aygun, Banu ^a   Hillenbrand, Claudia M ^a   Ware, Russell E ^a   Onciu, Mihaela ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Hemosiderosis; Liver biopsy; Liver fibrosis; Sickle cell anemia; Thalassemia

Indexed keywords

IRON;

ADOLESCENT; ADULT; ARTICLE; CHELATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRON OVERLOAD; LIVER BIOPSY; LIVER FIBROSIS; LIVER INJURY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SICKLE CELL ANEMIA; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BETA-THALASSEMIA; BIOPSY; BLOOD TRANSFUSION; CHELATION THERAPY; CHILD; FEMALE; HUMANS; IRON; IRON CHELATING AGENTS; IRON OVERLOAD; LIVER; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; TISSUE DISTRIBUTION; YOUNG ADULT;

EID: 77953855069     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2010.01449.x     Document Type: Article

References (29)

1. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998 339 : 5 11.
2. Adams RJ, Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005 353 : 2769 2778.
3. Lee MT, Piomelli S, Granger S, Miller ST, Harkness S, Brambilla DJ, Adams RJ. Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results. Blood 2006 108 : 847 852.
4. McCarville MB, Goodin GS, Fortner G, Li CS, Smeltzer MP, Adams R, Wang W. Evaluation of a comprehensive transcranial doppler screening program for children with sickle cell anemia. Pediatr Blood Cancer 2008 50 : 818 821.
5. Piperno A. Classification and diagnosis of iron overload. Haematologica 1998 83 : 447 455.
6. Olivieri NF. Progression of iron overload in sickle cell disease. Semin Hematol 2001 38 (1 Suppl. 1 57 62.
7. Risdon RA, Barry M, Flynn DM. Transfusional iron overload: the relationship between tissue iron concentration and hepatic fibrosis in thalassaemia. J Pathol 1975 116 : 83 95.
8. Thakerngpol K, Fucharoen S, Boonyaphipat P, Srisook K, Sahaphong S, Vathanophas V, Stitnimankarn T. Liver injury due to iron overload in thalassemia: histopathologic and ultrastructural studies. Biometals 1996 9 : 177 183.
9. Deugnier YM, Loreal O, Turlin B, Guyader D, Jouanolle H, Moirand R, Jacquelinet C, Brissot P. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 1992 102 : 2050 2059.
10. Berdoukas V, Bohane T, Tobias V, De SK, Fraser I, Aessopos A, Lindeman R. Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy. Hematol J 2005 5 : 572 578.
11. Jensen PD, Jensen FT, Christensen T, Nielsen JL, Ellegaard J. Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: a study in adult patients with acquired anemias. Blood 2003 101 : 91 6.
12. Bansal SS, Halket JM, Bomford A, Simpson RJ, Vasavda N, Thein SL, Hider RC. Quantitation of hepcidin in human urine by liquid chromatography-mass spectrometry. Anal Biochem 2009 384 : 245 253.
13. Fernandes A, Preza GC, Phung Y, De Domenico I, Kaplan J, Ganz T, Nemeth E. The molecular basis of hepcidin-resistant hereditary hemochromatosis. Blood 2009 114 : 437 443.
14. Walter PB, Fung EB, Killilea DW, Jiang Q, Hudes M, Madden J, Porter J, Evans P, Vichinsky E, Harmatz P. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol 2006 135 : 254 263.
15. Hankins JS, McCarville MB, Loeffler RB, Smeltzer MP, Onciu M, Hoffer FA, Li CS, Wang WC, Ware RE, Hillenbrand CM. R2* magnetic resonance imaging of the liver in patients with iron overload. Blood 2009 113 : 4853 4855.
16. Hoffer FA. Liver biopsy methods for pediatric oncology patients. Pediatr Radiol 2000 30 : 481 488.
17. Ishak K, Baptista A, Bianchi L, Callea F, De GJ, Gudat F, Denk H, Desmet V, Korb G, MacSween RN. Histological grading and staging of chronic hepatitis. J Hepatol 1995 22 : 696 699.
18. Olivieri NF. The beta-thalassemias. N Engl J Med 1999 341 : 99 109.
19. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996 110 : 1107 1119.
20. Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, Martin M, Koren G, Cohen AR. Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med 1994 331 : 574 578.
21. Ghugre NR, Gonzalez-Gomez I, Butensky E, Noetzli L, Fischer R, Williams R, Harmatz P, Coates TD, Wood JC. Patterns of hepatic iron distribution in patients with chronically transfused thalassemia and sickle cell disease. Am J Hematol 2009 84 : 480 483.
22. Bonkovsky HL. Iron and the liver. Am J Med Sci 1991 301 : 32 43.
23. Prati D, Maggioni M, Milani S, et al. Clinical and histological characterization of liver disease in patients with transfusion-dependent beta-thalassemia. A multicenter study of 117 cases. Haematologica 2004 89 : 1179 1186.
24. Vatanavicharn S, Anuwatanakulchai M, Tuntawiroon M, Suwanik R, Wasi P. Iron absorption in patients with beta-thalassaemia/haemoglobin E disease and the effect of splenectomy. Acta Haematol 1983 69 : 414 416.
25. Pippard MJ, Callender ST, Warner GT, Weatherall DJ. Iron absorption and loading in beta-thalassaemia intermedia. Lancet 1979 2 : 819 821.
26. Hershko C. Determinants of fecal and urinary iron excretion in desferrioxamine-treated rats. Blood 1978 51 : 415 423.
27. Witzleben L, Wyatt P. The effect of long survival on the pathology of thalassaemia major. J Pathol Bacteriol 1961 82 : 1 12.
28. Berry CL, Marshall WC. Iron distribution in the liver of patients with thalassaemia major. Lancet 1967 1 : 1031 1033.
29. Harmatz P, Butensky E, Quirolo K, Williams R, Ferrell L, Moyer T, Golden D, Neumayr L, Vichinsky E. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood 2000 96 : 76 9.